Clinical trial

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

NCT01812668

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-03-01

PhaseNA

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2021-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adenocarcinoma of the Prostateunresolved

Hormone-resistant Prostate Cancerunresolved

Recurrent Prostate Cancerunresolved

Stage IV Prostate Cancerunresolved

Interventions

cabozantinib-s-malateDRUG

fluorine F 18 d-FMAURADIATION

positron emission tomographyPROCEDURE

pharmacological studyOTHER

laboratory biomarker analysisOTHER

Sponsors & collaborators

Barbara Ann Karmanos Cancer Institutelead sponsor

Mapped research locations

DetroitMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01812668 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.